Lung Cancer Location: a Repository

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT00578084
First received: December 19, 2007
Last updated: October 7, 2013
Last verified: September 2013

December 19, 2007
October 7, 2013
June 2006
July 2013   (final data collection date for primary outcome measure)
examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location [ Time Frame: ongoing-database ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00578084 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Lung Cancer Location: a Repository
Lung Cancer Location: A Prospective Repository

The purpose of this repository is to prospectively examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location. The data collected in this repository may be used to influence our current standard of care and streamline indications for EUS.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Subjects with known or suspected lung cancer will be identified by referral to the thoracic surgeon or ultrasonographer at the Veterans Affairs Hospital or Indiana University Medical Center.

Lung Cancer
Not Provided
  • surgery
    those subjects who went to surgery to treat their lung cancer
  • no surgery
    those subjects who did not go to surgery for their lung cancer
  • NSCLC
    subjects with NSCLC
  • Small cell lung cancer
    those with small cell lung cancer
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
200
September 2013
July 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects undergoing EUS evaluation of a mediastinal mass, or suspected/known lung cancer
  • Subjects with a prior history of lung cancer
  • Subjects referred to thoracic surgery for evaluation of a suspected/known lung cancer

Exclusion Criteria:

  • Altered mental status that would prohibit the giving and understanding of informed consent
  • Dementia
  • Psychiatric illness that would preclude adequate compliance with communication for this protocol
  • Prisoners
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00578084
0604-76, IRB # 0604-76
No
Indiana University
Indiana University
Not Provided
Principal Investigator: Julia LeBlanc, MD, MPH Indiana University
Indiana University
September 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP